Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/26/1998WO1998012312A1 Antisense gene therapy for rna viruses
03/26/1998WO1998012306A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998WO1998012302A1 Weight control pathway genes and uses therefor
03/26/1998WO1998012228A1 Polymers containing polysaccharides such as alginates or modified alginates
03/26/1998WO1998012227A1 Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
03/26/1998WO1998012226A1 Methods of ameliorating cancer and of inhibiting angiogenesis by using fibronectin
03/26/1998WO1998012225A2 Process for producing a plasma protein-containing medicament
03/26/1998WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998WO1998012223A1 Novel human interferon-inducible protein
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998012219A1 Methionine, penicillamine and cysteine-analogue containing peptides having immunomodulating activity
03/26/1998WO1998012218A1 Tri- or polysulphide containing peptides having immunomodulating activity
03/26/1998WO1998012217A1 Heterodimer peptides with immunomodulatory effect
03/26/1998WO1998012216A1 Methionine containing peptides having immunomodulatory effect
03/26/1998WO1998012215A1 Penicillamine containing peptides having immunomodulatory effect
03/26/1998WO1998012214A1 Cysteine analogue containing peptides having immunomodulatory effect
03/26/1998WO1998012213A2 Cysteine containing peptides
03/26/1998WO1998012212A1 Nucleopeptide complexes, cosmetic and pharmaceutical compositions containing them and their uses
03/26/1998WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012204A1 Human b-cell translocation genes-2 and 3
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011918A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998WO1998011917A1 Hiv-1 therapy with il-2 and anti-tnf antibody
03/26/1998WO1998011913A1 Use of igf-i for the treatment of polycystic kidney disease and related indications
03/26/1998WO1998011912A1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
03/26/1998WO1998011911A1 Use of cytokines and cytotoxic substances in a new method to treat tumors
03/26/1998WO1998011910A1 Prevention of gastrointestinal damage
03/26/1998WO1998011909A1 Use of proteins as agents against autoimmune diseases
03/26/1998WO1998011908A1 Combination therapy for treatment of arthritic diseases
03/26/1998WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998WO1998011906A1 Phospholipid drug derivatives
03/26/1998WO1998011903A1 Chitosan derivatives for treating malignant tumours
03/26/1998WO1998011896A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998WO1998011894A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998WO1998011828A1 Stent lining
03/26/1998WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998WO1998011778A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases
03/26/1998WO1998005770A3 Antisense rna with a secondary structure
03/26/1998WO1998004589A3 Production of recombinant plasma gelsolin containing a disulfide bond
03/26/1998WO1998004280A3 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
03/26/1998WO1998003538A3 Signal-regulated, cleavage-mediated toxins
03/26/1998WO1998001159A3 Composition for enhanced uptake of polar drugs from mucosal surfaces
03/26/1998WO1998000695A3 Tat-sf: cofactor for stimulation of transcriptional elongation by hiv-1 tat
03/26/1998WO1998000551A3 Gene encoding hyaluronan synthase
03/26/1998WO1997049832A3 Method of identifying cytochrome p450
03/26/1998WO1997048724A3 Human metabotropic glutamate receptor
03/26/1998WO1997048370A3 Vaccines comprising synthetic genes
03/26/1998WO1997046672A3 Antisense nucleic acids and hammerhead ribozymes
03/26/1998WO1997040809A3 METHOD OF ENHANCING EFFECT OF NEUROTROPHIN WITH ANALOGUES OF p75NTR367-379
03/26/1998WO1997040072A3 Adam proteins and uses thereof
03/26/1998WO1997040063A3 Pathogenic escherichia coli associated protein espa
03/26/1998WO1997039030A3 Secreted proteins
03/26/1998WO1997035990A3 Histone deacetylases, and uses related thereto
03/26/1998DE19723690A1 Use of Fc-gamma receptor antibodies
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19641180A1 Verfahren zur Darstellung von APP-Sekretase Modulation und deren Verwendung als Mittel zur Behandlung der Alzheimer'schen Erkrankung A method for representation of APP-secretase modulation and their use as agents for the treatment of Alzheimer's disease
03/26/1998DE19639346A1 Production of recombinant staphylokinase
03/26/1998DE19639103A1 DNA construct with inhibitory mutation and corrective mutation
03/26/1998DE19638870A1 Verbindungen mit antimykotischer und cytostatischer Wirkung, Herstellungsverfahren, Mittel und DSM 11 092 Compounds with antifungal and cytostatic effect, manufacturing methods, means and DSM 11092
03/26/1998CA2269092A1 Rh blood group antigen compositions and methods of use
03/26/1998CA2267288A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266684A1 Use of antibodies to cd45r leukocyte antigens for immunomodulation
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998CA2266585A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes
03/26/1998CA2266532A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents
03/26/1998CA2266425A1 Human b-cell translocation genes-2 and 3
03/26/1998CA2266404A1 Phospholipid drug derivatives
03/26/1998CA2266346A1 Use of proteins as agents against autoimmune diseases
03/26/1998CA2266341A1 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
03/26/1998CA2266339A1 Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
03/26/1998CA2265972A1 Use of igf-i for the treatment of polycystic kidney disease and related indications
03/26/1998CA2265827A1 Combination therapy for reducing the risks associated with cardiovascular disease
03/26/1998CA2265571A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
03/26/1998CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2264542A1 Human gtp binding protein gamma-3
03/26/1998CA2263821A1 Novel human interferon-inducible protein
03/26/1998CA2263818A1 Novel tumor proteins
03/26/1998CA2238043A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
03/26/1998CA2236165A1 Novel polypeptide from haemophilus paragallinarum and process for preparing the same
03/25/1998EP0831100A1 Novel peptide derivatives
03/25/1998EP0830604A1 Methods and uses for apoptin
03/25/1998EP0830456A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830452A1 Immune-evading proteins
03/25/1998EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
03/25/1998EP0830381A1 Chitin hydrogels, methods of their production and use
03/25/1998EP0830377A1 Glucagon-like peptide-2 and its therapeutic use
03/25/1998EP0830376A1 Process for producing erythropoietin containing no animal proteins
03/25/1998EP0830375A1 Human inhibitor of apoptosis gene 1
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
03/25/1998EP0830373A1 Cd6 ligand
03/25/1998EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
03/25/1998EP0830371A1 IMIDAZO 1,5a]PYRIDINE DERIVED SERINE PROTEASE INHIBITORS
03/25/1998EP0830368A1 Novel carbamate-based cationic lipids
03/25/1998EP0830147A1 Polymyxin conjugates
03/25/1998EP0830143A1 Use of leukemia inhibitory factor and endothelin antagonists
03/25/1998EP0830142A1 Viral agent associated with mystery swine disease
1 ... 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 ... 3163